Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
226M
-
Number of holders
-
1152
-
Total 13F shares, excl. options
-
217M
-
Shares change
-
-4.02M
-
Total reported value, excl. options
-
$69.5B
-
Value change
-
-$1.21B
-
Put/Call ratio
-
1.26
-
Number of buys
-
476
-
Number of sells
-
-490
-
Price
-
$321.09
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q4 2020
1,284 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q4 2020.
Elevance Health, Inc. - Common Stock (ELV) has 1,152 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 217M shares
of 226M outstanding shares and own 95.91% of the company stock.
Largest 10 shareholders include BlackRock Inc. (22.4M shares), VANGUARD GROUP INC (19M shares), PRICE T ROWE ASSOCIATES INC /MD/ (12M shares), STATE STREET CORP (10.7M shares), WELLINGTON MANAGEMENT GROUP LLP (10M shares), FMR LLC (8.73M shares), Capital International Investors (4.18M shares), BAILLIE GIFFORD & CO (3.95M shares), GEODE CAPITAL MANAGEMENT, LLC (3.73M shares), and BANK OF AMERICA CORP /DE/ (3.61M shares).
This table shows the top 1152 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.